Skip to content
Home/Companies/MedTech/Endomag
EN

Endomag

MedTech·UK·Exited 2024·Held 1yr

Endomag is a MedTech company, headquartered in UK.

Entry
2023
Hold
1yr
Exit
2024
Est. EV
–

Who owns Endomag?

Endomag was owned by Claret Capital Partners through Claret European Growth Capital Fund III (2021 vintage) from 2023 to 2024, exited via Trade Sale. Across its history, Endomag has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-05-29

Claret Capital Partners
Most recent investor
Claret Capital Partners
Claret European Growth Capital Fund III · 2021 · Private Debt
2 ownership periods · full history below

Key facts

HQUK
SectorMedTech
StatusAcquired
Key takeaways
  • ·Fully exited in 2024.
  • ·Average hold across 2 realized cycles: 4 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2024 to .
Co-invest · 2 holders · 2018 · 2024
Molten Ventures
Molten VenturesExited 2024
2018 · 2024 · Molten Ventures Balance Sheet · 2016 · Balance Sheet
Trade Sale · to
MOIC
–
Claret Capital Partners
Claret Capital PartnersExited 2024
2023 · 2024 · Claret European Growth Capital Fund III · 2021 · Private Debt
Trade Sale · to
MOIC
–

More from Claret European Growth Capital Fund III

Other portfolio companies in the same fund.

Spiideo
Active
AI/MLSweden· 2023
Urban Sports Club
Exited 2025
ConsumerGermany· 2021
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Serres
Active
G Square Healthcare PEFinland· 2026
Stago
Active
ARCHIMEDFrance· 2026
Amoena
Active
Apera Asset ManagementGermany· 2025
Amotio
Active
Development Bank of WalesUK· 2025
Data refreshed weekly · Sourced from public filings